Giuseppe Pantaleo

Division of Immunology and Allergy, Lausanne University Hospital

Affiliated withLausanne University Hospital

Research Area

Biography

Giuseppe Pantaleo has not added Biography.
If you are Giuseppe Pantaleo and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2019

Other Publications

Article	Year
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nature reviews. Immunology\| PubMed ID: 16622477	2006
Long sequence duplications, repeats, and palindromes in HIV-1 gp120: length variation in V4 as the product of misalignment mechanism. Virology\| PubMed ID: 20106497	2010
Poxvirus vector-based HIV vaccines. Current opinion in HIV and AIDS\| PubMed ID: 20978379	2010
Modulation of human memory T-cell function by different antigen-presenting cells. European journal of immunology\| PubMed ID: 22144294	2012
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes. Journal of virology\| PubMed ID: 22491454	2012
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity. PloS one\| PubMed ID: 22848738	2012
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients. European journal of immunology\| PubMed ID: 22930439	2012
Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. The Journal of experimental medicine\| PubMed ID: 23254284	2013
Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nature medicine\| PubMed ID: 23475201	2013
Vaccine and immunotherapeutic interventions. Current opinion in HIV and AIDS\| PubMed ID: 23478912	2013
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells. PLoS pathogens\| PubMed ID: 23853580	2013
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. The Lancet. Infectious diseases\| PubMed ID: 24525316	2014
The immune space: a concept and template for rationalizing vaccine development. AIDS research and human retroviruses\| PubMed ID: 24857015	2014
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. The Journal of clinical investigation\| PubMed ID: 24911151	2014
Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. The Journal of experimental medicine\| PubMed ID: 25225461	2014
Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 25362202	2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. PLoS pathogens\| PubMed ID: 26379282	2015
Immune correlates of vaccine protection against HIV-1 acquisition. Science translational medicine\| PubMed ID: 26491081	2015
A case for preART-adjusted endpoints in HIV therapeutic vaccine trials. Vaccine\| PubMed ID: 26826543	2016
Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. Human immunology\| PubMed ID: 27085791	2016
PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nature medicine\| PubMed ID: 27239760	2016
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change. Current opinion in HIV and AIDS\| PubMed ID: 27607591	2016
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies. Science translational medicine\| PubMed ID: 28100833	2017
B-cell abnormalities and impact on antibody response in HIV infection. Current opinion in HIV and AIDS\| PubMed ID: 28422784	2017
Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania. PLoS neglected tropical diseases\| PubMed ID: 28759590	2017
Targeted Immune Interventions for an HIV-1 Cure. Trends in molecular medicine\| PubMed ID: 28890135	2017
Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial. EBioMedicine\| PubMed ID: 28970080	2017
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees. Journal of virology\| PubMed ID: 29386288	2018
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates. Journal of virology\| PubMed ID: 29437967	2018
Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4 T cell responses in Tanzanian adults with latent or active tuberculosis. Immunity, inflammation and disease\| PubMed ID: 29642283	2018
CD32 and PD-1 Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals. Journal of virology\| PubMed ID: 29976671	2018
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. The Journal of clinical investigation\| PubMed ID: 30148455	2018
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial. Vaccine\| PubMed ID: 30181045	2018
Comparative analysis and generation of a robust HIV-1 DNA quantification assay. Journal of virological methods\| PubMed ID: 30326210	2019
Antibodies to and reproductive health issues in women with SLE: a case-control study. Lupus science & medicine\| PubMed ID: 30538819	2018
HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. Journal of virology\| PubMed ID: 30541853	2019
Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption. PloS one\| PubMed ID: 30699178	2019
Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1). The Journal of general virology\| PubMed ID: 30896385	2019
Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. The lancet. HIV\| PubMed ID: 31047670	2019
Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway. The Journal of experimental medicine\| PubMed ID: 31123083	2019
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS pathogens\| PubMed ID: 31329640	2019
Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural Tanzania. BMC research notes\| PubMed ID: 31492170	2019
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial. The Journal of clinical investigation\| PubMed ID: 31566579	2019
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial. The lancet. HIV\| PubMed ID: 31601541	2019
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8 T lymphocyte exhaustion. BMC biotechnology\| PubMed ID: 31623599	2019
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01. Cell host & microbe\| PubMed ID: 31653484	2019
Antigenic competition in CD4 T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science translational medicine\| PubMed ID: 31748227	2019